The legal marijuana industry is budding before our eyes. What had once been considered a taboo industry that was swept under the rug by lawmakers has now become a front-and-center issue, as well as a big-time moneymaker for investors and companies involves in the pot industry.

Understanding the effects of cannabis is crucial to determining the legal status of the substance, which is still a schedule I drug in the Controlled Substances Act. In learning more about cannabis, researchers from The University of New Mexico (UNM) recently examined its use as a pain reliever. According to the results of their study, on a scale of 0 to 10, the pain level of the user decreased by approximately three points with the use of cannabis.

A hearing officer has endorsed key provisions of a plan designed to shore up cannabis supplies to New Mexico’s medical marijuana program without flooding the expanding market, according to recommendations released on Friday.

State Health Department Secretary Kathyleen Kunkel now has the final say on whether to limit medical cannabis cultivation to 1,750 mature plants per producer. In recommendations released Friday, that production cap was endorsed by an official assigned to monitor public hearings in July.

Dozens of medical cannabis producers in the state are divided on whether the proposed plant limits will ensure adequate supplies to patients.

A New Mexico judge has ruled that recent changes to the regulations affecting the state’s medical marijuana program mean that out of state residents will now qualify to buy cannabis at government-run dispensaries.

“The [word] replacement is a clear sign of legislative intent to widen the reach of eligibility for the New Mexico medical cannabis program,” wrote Santa Fe Judge Bryan Biedscheid, who presided over the proceeding.

The state senator who sponsored the legislation that changed the language of the bill, Democrat Jerry Ortíz y Pino, said that the revision was originally due to a desire to cover individuals who had their medical marijuana cards in other states, or “reciprocal patients.”

Hemp industry participants in the U.S. state of New Mexico now have some regulatory clarity after the state’s Environment Department put temporary rules into effect.

The rules cover the extraction, manufacturing, processing storage and transportation of hemp and products derived from the crop.

“This temporary rule, to be in place no more than 180 days, will allow those in the hemp industry to begin operating in New Mexico and ensures the resulting products are safe for consumers while permanent regulations are developed,” said the Department late last week.

On Monday, cannabis officially become decriminalized in New Mexico, writes Calvin Hughes.

Some three months after legislation was approved by New Mexico Gov. Michelle Lujan Grisham (D) marijuana possession officially became decriminalized in the state this week. Individuals caught with as much as a half ounce of cannabis will now receive a $50 fine as opposed to jail time.

New Mexico is proposing new cannabis generation standards intended to shore up provisions to its therapeutic pot program without flooding the quickly extending business sector.

The Department of Health distributed a proposition Tuesday to restrain medicinal cannabis development to 1,750 develop plants for every authorized maker.

The earlier 450-plant farthest point was struck during this time in light of a claim by the state’s biggest dealer and the mother of a youngster who is dependent on cannabis oil to treat a type of epilepsy.

Juvenile seedlings shorter than 8 inches won’t check toward the breaking point so makers can explore different avenues regarding plant strains.

A state at the forefront of the U.S. opioid and drug overdose epidemic is turning to its medical marijuana program to reduce suffering from drug use and addiction.

New Mexico health officials on Thursday expanded the list of qualifying conditions for the state's medical cannabis program to include opioid use disorder, joining several other states. Other qualifying conditions that were added include Alzheimer's disease, autism spectrum disorder and three degenerative neurological disorders.